6 completed, 2 terminated. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Terminated 2 |
| Phase 2 | 1 | Completed 1 |
Follow Stage IV Bladder Cancer: new trials by email Literature Review of Stage IV Bladder Cancer trials Research Report on Stage IV Bladder Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma Enzyme Inhibitor Therapy, Laboratory Biomarker Analysis, Nivolumab - Lymphoma, Metastatic Malignant Solid Neoplasm | Phase 1 | Completed | Rutgers, The State University of New Jersey | 14 | 2017-10-03 | 2023-12-06 |
| Sirolimus, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Bladder Cancer Cisplatin, Gemcitabine Hydrochloride, Sirolimus - Recurrent Bladder Carcinoma, Stage II Bladder Cancer | Phase 1 / Phase 2 | Completed | University of Washington | 21 | 2013-10-01 | 2017-10-20 |
| Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer gemcitabine hydrochloride, veliparib, diagnostic laboratory biomarker analysis - Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer | Phase 1 | Terminated | National Cancer Institute (NCI) | 44 | 2011-01-01 | 2013-07-02 |
| Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy Recombinant Fowlpox-TRICOM Vaccine, Recombinant Fowlpox GM-CSF Vaccine Adjuvant, Therapeutic Conventional Surgery - Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 21 | 2003-10-01 | 2014-12-23 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction erlotinib hydrochloride, laboratory biomarker analysis - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma | Phase 1 | Completed | National Cancer Institute (NCI) | 75 | 2001-12-01 | 2013-01-16 |
| Decitabine in Treating Patients With Advanced Solid Tumors decitabine, pharmacological study, laboratory biomarker analysis - Male Breast Cancer, Recurrent Bladder Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2001-12-01 | 2013-02-07 |
| Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu recombinant interleukin-12, ABI-007/carboplatin/trastuzumab - Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 1999-08-01 | 2013-02-28 |
| Gene Therapy in Treating Patients With Advanced Bladder Cancer Ad5CMV-p53 gene - Recurrent Bladder Cancer, Stage I Bladder Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 1998-05-01 | 2013-01-23 |
Urinary Bladder Neoplasms (8) · Carcinoma, Non-Small-Cell Lung (4) · Breast Neoplasms (3) · Breast Neoplasms, Male (3) · Pancreatic Neoplasms (3) · Squamous Cell Carcinoma of Head and Neck (3) · Anus Neoplasms (2) · Carcinoma, Hepatocellular (2) · Carcinoma, Ovarian Epithelial (2) · Carcinoma, Renal Cell (2) · Colonic Neoplasms (2) · Esophageal Neoplasms (2) · Melanoma (2) · Prostatic Neoplasms (2) · Rectal Neoplasms (2)
Female Urogenital Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (8) · Male Urogenital Diseases (8) · Neoplasms (8) · Neoplasms by Site (8) · Urinary Bladder Diseases (8) · Urogenital Diseases (8) · Urogenital Neoplasms (8) · Urologic Diseases (8) · Urologic Neoplasms (8) · Bronchial Neoplasms (4) · Carcinoma, Bronchogenic (4) · Lung Diseases (4) · Lung Neoplasms (4) · Neoplasms by Histologic Type (4)
Cisplatin (2) · Gemcitabine (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · Cystectomy (1) · Decitabine (1) · Erlotinib Hydrochloride (1) · Interleukin-12 (1) · Interleukin-12 Subunit p35 (1) · Nivolumab (1) · Platinum (1) · Sirolimus (1) · Trastuzumab (1) · advexin (1) · pembrolizumab (1) · veliparib (1)
National Cancer Institute (NCI) (6) · Rutgers, The State University of New Jersey (1) · University of Washington (1)
United States (8)
Antonius Miller (1) · Biren Saraiya (1) · Jeffrey Weber (1) · Lance Pagliaro (1) · Leonard Appleman (1) · Robert Montgomery (1) · Robert Weiss (1) · William Carson (1)
P30CA072720 (2), P30CA015704 (1), R21CA076233 (1), U01CA062505 (1), U01CA076576 (1), U01CA099168 (1), U01CA132194 (1), U10CA031946 (1)